Safety and Efficacy of Upadacitinib for Atopic Dermatitis in Japan: 2-Year Interim Results from the Phase 3 Rising Up Study

被引:0
|
作者
Norito Katoh
Yukihiro Ohya
Hiroyuki Murota
Masanori Ikeda
Xiaofei Hu
Kimitoshi Ikeda
John Liu
Takuya Sasaki
Eliza M. Raymundo
Henrique D. Teixeira
Hidehisa Saeki
机构
[1] Kyoto Prefectural University,Department of Dermatology
[2] National Center for Child Health and Development,Allergy Center
[3] Nagasaki University Graduate School of Biomedical Sciences,Department of Dermatology
[4] Okayama University School of Medicine,Department of Pediatrics
[5] Fukuyama Municipal Hospital,Department of Dermatology
[6] AbbVie Inc.,undefined
[7] AbbVie GK,undefined
[8] Nippon Medical School,undefined
来源
Dermatology and Therapy | 2023年 / 13卷
关键词
Atopic dermatitis; Clinical trial; Eczema; Janus kinase inhibitors; Safety; Topical corticosteroids; Upadacitinib;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:221 / 234
页数:13
相关论文
共 50 条
  • [1] Safety and Efficacy of Upadacitinib for Atopic Dermatitis in Japan: 2-Year Interim Results from the Phase 3 Rising Up Study
    Katoh, Norito
    Ohya, Yukihiro
    Murota, Hiroyuki
    Ikeda, Masanori
    Hu, Xiaofei
    Ikeda, Kimitoshi
    Liu, John
    Sasaki, Takuya
    Raymundo, Eliza M.
    Teixeira, Henrique D.
    Saeki, Hidehisa
    [J]. DERMATOLOGY AND THERAPY, 2023, 13 (01) : 221 - 234
  • [2] Safety and Efficacy of Upadacitinib for Atopic Dermatitis in Japan: Analysis of the 3-Year Phase 3 Rising Up Study
    Norito Katoh
    Masanori Ikeda
    Yukihiro Ohya
    Hiroyuki Murota
    Xiaofei Hu
    John Liu
    Hayato Niiyama
    Takuya Sasaki
    Eliza M. Raymundo
    Hidehisa Saeki
    [J]. Dermatology and Therapy, 2024, 14 : 213 - 232
  • [3] Safety and Efficacy of Upadacitinib for Atopic Dermatitis in Japan: Analysis of the 3-Year Phase 3 Rising Up Study
    Katoh, Norito
    Ikeda, Masanori
    Ohya, Yukihiro
    Murota, Hiroyuki
    Hu, Xiaofei
    Liu, John
    Niiyama, Hayato
    Sasaki, Takuya
    Raymundo, Eliza M.
    Saeki, Hidehisa
    [J]. DERMATOLOGY AND THERAPY, 2024, 14 (01) : 213 - 232
  • [4] Acne Among Japanese Patients with Atopic Dermatitis Receiving Upadacitinib in the Phase 3 Rising Up Study
    Nobukazu Hayashi
    Masanori Ikeda
    John Liu
    Eliza Raymundo
    Yingyi Liu
    Takuya Sasaki
    Kenshi Yamasaki
    [J]. Dermatology and Therapy, 2023, 13 : 1817 - 1830
  • [5] Acne Among Japanese Patients with Atopic Dermatitis Receiving Upadacitinib in the Phase 3 Rising Up Study
    Hayashi, Nobukazu
    Ikeda, Masanori
    Liu, John
    Raymundo, Eliza
    Liu, Yingyi
    Sasaki, Takuya
    Yamasaki, Kenshi
    [J]. DERMATOLOGY AND THERAPY, 2023, 13 (08) : 1817 - 1830
  • [6] Efficacy and Safety of Upadacitinib in Patients with Psoriatic Arthritis: 2-Year Results from the Phase 3 SELECT-PsA 1 Study
    Iain B. McInnes
    Koji Kato
    Marina Magrey
    Joseph F. Merola
    Mitsumasa Kishimoto
    Derek Haaland
    Liang Chen
    Yuanyuan Duan
    Jianzhong Liu
    Ralph Lippe
    Peter Wung
    [J]. Rheumatology and Therapy, 2023, 10 : 275 - 292
  • [7] Efficacy and Safety of Upadacitinib in Patients with Psoriatic Arthritis: 2-Year Results from the Phase 3 SELECT-PsA 1 Study
    McInnes, Iain B.
    Kato, Koji
    Magrey, Marina
    Merola, Joseph F.
    Kishimoto, Mitsumasa
    Haaland, Derek
    Chen, Liang
    Duan, Yuanyuan
    Liu, Jianzhong
    Lippe, Ralph
    Wung, Peter
    [J]. RHEUMATOLOGY AND THERAPY, 2023, 10 (01) : 275 - 292
  • [8] LONG-TERM EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS: 2-YEAR RESULTS FROM THE PHASE 3 SELECT-PSA 1 STUDY
    Mcinnes, I.
    Kato, K.
    Magrey, M.
    Merola, J. F.
    Kishimoto, M.
    Haaland, D.
    Chen, L.
    Duan, Y.
    Liu, J.
    Lippe, R.
    Wung, P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 260 - 261
  • [9] Efficacy and safety of switching from dupilumab to upadacitinib versus continuous upadacitinib in moderate-to-severe atopic dermatitis: Results from an open-label extension of the phase 3, randomized, controlled trial (Heads Up)
    Blauvelt, Andrew
    Ladizinski, Barry
    Prajapati, Vimal H.
    Laquer, Vivian
    Fischer, Alison
    Eisman, Samantha
    Hu, Xiaofei
    Wu, Tianshuang
    Calimlim, Brian M.
    Kaplan, Blair
    Liu, Yingyi
    Teixeira, Henrique D.
    Liu, John
    Eyerich, Kilian
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : 478 - 485
  • [10] A phase 3 randomized, multicenter, double-blind study to evaluate the safety of upadacitinib in combination with topical corticosteroids in adolescent and adult patients with moderate-to-severe atopic dermatitis in Japan (Rising Up) An interim 24-week analysis
    Katoh, Norito
    Ohya, Yukihiro
    Murota, Hiroyuki
    Ikeda, Masanori
    Hu, Xiaofei
    Ikeda, Kimitoshi
    Liu, John
    Sasaki, Takuya
    Chu, Alvina D.
    Teixeira, Henrique D.
    Saeki, Hidehisa
    [J]. JAAD INTERNATIONAL, 2022, 6 : 27 - 36